U.S. FDA Warning: Stolen Advair Diskus inhalers pose risk(Comments RSS)
The U.S. Food and Drug Administration (FDA) is warning consumers not
to use inhalers stolen from a Virginia warehouse after some of the
pilfered medicine turned up in some pharmacies.
The stolen Advair Diskus inhalers (fluticasone propionate and
salmeterol inhalation powder) were found recently - the first batch
known to have hit the supply chain since the August 2009 theft. As
the investigation continues, FDA officials warned the public that
more of the stolen inhalers could still be on the market.
More than 25,000 of the inhalers were stolen from drug maker
GlaxoSmithKline's distribution center near Richmond, Va., last year.
They are set to expire in September. FDA experts are advising anyone
who uses the Advair Diskus inhaler to check the label for the
following lot numbers:
Lot 9ZP2255 - NDC 0173-0696-00, Advair Diskus 250/50, 60 Dose Lot
9ZP3325 - NDC 0173-0697-00, Advair Diskus 500/50, 60 Dose
Patients who have inhalers with matching lot numbers should
discontinue use and call GlaxoSmithKline's Customer Response Center
at 888-825-5249.
See Alert: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm217879.htm
to use inhalers stolen from a Virginia warehouse after some of the
pilfered medicine turned up in some pharmacies.
The stolen Advair Diskus inhalers (fluticasone propionate and
salmeterol inhalation powder) were found recently - the first batch
known to have hit the supply chain since the August 2009 theft. As
the investigation continues, FDA officials warned the public that
more of the stolen inhalers could still be on the market.
More than 25,000 of the inhalers were stolen from drug maker
GlaxoSmithKline's distribution center near Richmond, Va., last year.
They are set to expire in September. FDA experts are advising anyone
who uses the Advair Diskus inhaler to check the label for the
following lot numbers:
Lot 9ZP2255 - NDC 0173-0696-00, Advair Diskus 250/50, 60 Dose Lot
9ZP3325 - NDC 0173-0697-00, Advair Diskus 500/50, 60 Dose
Patients who have inhalers with matching lot numbers should
discontinue use and call GlaxoSmithKline's Customer Response Center
at 888-825-5249.
See Alert: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm217879.htm


Add New Comment